Medipost Co Ltd (XKRX:078160) Share Price

Company Profile

Business description
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.
Contact
21, Daewangpangyo-ro 644
Bundang-gu
Gyeonggi-do
Seongnam
KOR
T: +82 234656650
http://www.medi-post.co.kr
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
324

Recommended

Going back to my original thesis to evaluate a position.

Mark LaMonica, CFA | 08 August 2025

This company dominates its industry and could be flirting with regulatory intervention.

Roy Van Keulen | 07 August 2025

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.

Mark Giarelli | 07 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,076.60	25.40	-0.28%
CAC 40	7,743.00	33.68	0.44%
DAX 40	24,162.86	29.64	-0.12%
Dow JONES (US)	44,175.61	206.97	0.47%
FTSE 100	9,095.73	5.04	-0.06%
HKSE	24,858.82	222.81	-0.89%
NASDAQ	21,450.02	207.32	0.98%
Nikkei 225	41,820.48	761.33	1.85%
NZX 50 Index	12,844.63	42.47	-0.33%
S&P 500	6,389.45	49.45	0.78%
S&P/ASX 200	8,807.10	24.30	-0.28%
SSE Composite Index	3,635.13	4.54	-0.12%